‹ Back to screener

MEDANTA.NS Global Health Ltd.

Healthcare

Price history

2025-08-21 ₹1389.60
2026-08-21 ₹1409.40
Change over window +1.42%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 47.1%
Trailing 20-day average 57.6%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 404295 190517 47.12%
2026-08-27 1109587 387214 34.90%
2026-08-26 606668 273972 45.16%
2026-08-25 69432 41569 59.87%
2026-08-24 92480 62609 67.70%
2026-08-21 117802 88463 75.09%
2026-08-20 120892 61400 50.79%
2026-08-19 80452 42423 52.73%
2026-08-18 309148 219779 71.09%
2026-08-17 66949 33116 49.46%
2026-08-14 296264 206388 69.66%
2026-08-13 218806 126016 57.59%
2026-08-12 243269 140081 57.58%
2026-08-11 224097 101507 45.30%
2026-08-10 306259 161187 52.63%
2026-08-07 550910 414697 75.27%
2026-08-06 362251 254988 70.39%
2026-08-05 222083 134545 60.58%
2026-08-04 197187 118009 59.85%
2026-08-03 382840 184750 48.26%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers MEDANTA.NS to fetch more history.

Insider trading activity

No insider-trading disclosures on file — run python manage.py refresh_insider_trades --tickers MEDANTA.NS. (No stored disclosures may mean none have been fetched yet, or that NSE has genuinely published none for this company.)

Ratios as of FY2025-26 (Annual) · Price ₹1409.70 INR (live) · fetched 2026-08-23 22:31 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Ratios

P/E
68.07
P/E = Price / EPS
Source trace
P/E = Price / (ProfitOrLossAttributableToOwnersOfParent / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹1,409.70 / (₹5,564,600,000 / 268,690,000 shares) = ₹1,409.70 / ₹20.71 EPS
FY2025-26 · Annual filing
ROE
14.05%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitOrLossAttributableToOwnersOfParent / EquityAttributableToOwnersOfParent → ₹5,564,600,000 / ₹39,615,700,000 = 14.05%
FY2025-26 · Annual filing
Debt/Equity
0.30
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹11,900,460,000 / ₹39,615,700,000 = 0.30
FY2025-26 · Annual filing
Current Ratio
2.67
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹16,749,200,000 / ₹6,271,310,000 = 2.67
FY2025-26 · Annual filing
ROCE
15.44%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹7,951,520,000 / (₹39,615,700,000 + ₹11,900,460,000) = 15.44%
FY2025-26 · Annual filing
Dividend Yield
0.04%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹134,400,000 / 268,690,000 shares) / ₹1,409.70 = ₹0.50 / ₹1,409.70
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, 3.0y actual) 17.8%
Net Profit (3y) 7.9%
Revenue (5y, 3.0y actual) 17.8%
Net Profit (5y) 7.9%
Revenue (10y, 3.0y actual) 17.8%
Net Profit (10y) 7.9%

Operating Margin Trend

Eroding

FY2022-23 19.6%
FY2023-24 21.4%
FY2024-25 20.6%
FY2025-26 18.0%

ROCE Trajectory

FY2022-23 16.1%
FY2023-24 21.1%
FY2024-25 20.5%
FY2025-26 15.4%

Earnings Quality

No persistent gap detected

Net Profit CAGR 7.88% vs CFO CAGR 8.04% over 2.0y (2024-03-31 → 2026-03-31); most recent year: Net Profit +15.58% vs CFO +14.53%

Sector-Relative Percentile (Healthcare)

ROE 48th
ROCE 46th
Debt/Equity 28th
P/E 30th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q4 FY2023-24 Q1 FY2024-25 Q2 FY2024-25 Q3 FY2024-25 Q4 FY2024-25 Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q4 FY2025-26 Q1 FY2026-27 Source
Revenue ₹808.63 Cr. ₹861.08 Cr. ₹956.55 Cr. ₹943.44 Cr. ₹931.25 Cr. ₹1,030.84 Cr. ₹1,099.22 Cr. ₹1,121.05 Cr. ₹1,159.05 Cr. ₹1,304.05 Cr. RevenueFromOperations
Net Profit ₹127.38 Cr. incl. minority ₹127.35 Cr. ₹106.29 Cr. incl. minority ₹106.26 Cr. ₹130.82 Cr. ₹142.91 Cr. incl. minority ₹142.86 Cr. ₹101.40 Cr. incl. minority ₹101.38 Cr. ₹159.01 Cr. incl. minority ₹158.98 Cr. ₹158.44 Cr. incl. minority ₹158.40 Cr. ₹95.02 Cr. incl. minority ₹95.03 Cr. ₹143.99 Cr. incl. minority ₹141.65 Cr. ₹158.73 Cr. incl. minority ₹157.25 Cr. ProfitOrLossAttributableToOwnersOfParent

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers MEDANTA.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitOrLossAttributableToOwnersOfParent5564600000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital268690000.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets16749200000.0
CurrentLiabilities6271310000.0
EquityAttributableToOwnersOfParent39615700000.0
BorrowingsCurrent + BorrowingsNoncurrent11900460000.0

My notes